FLUTICASONE PROPIONATE AND SALMETEROL

FLUTICASONE PROPIONATE AND SALMETEROL was reported 60266 times

FLUTICASONE PROPIONATE AND SALMETEROL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INHALATION THERAPY 152 0.2413
1 EMERGENCY CARE EXAMINATION 85 0.1254
2 INTENTIONAL UNDERDOSE 540 0.0739
3 OXYGEN SUPPLEMENTATION 51 0.0689
4 LUNG LOBECTOMY 18 0.0549
5 LUNG OPERATION 43 0.0513
6 DEVICE USE ERROR 1463 0.0421
7 INTERCEPTED DRUG ADMINISTRATION ERROR 18 0.0410
8 INVESTIGATION 124 0.0395
9 PEAK EXPIRATORY FLOW RATE DECREASED 17 0.0386
10 LIFE SUPPORT 20 0.0357
11 PRODUCT COMPLAINT 878 0.0346
12 RESPIRATORY TRACT IRRITATION 36 0.0345
13 INCREASED VISCOSITY OF BRONCHIAL SECRETION 22 0.0345
14 OROPHARYNGEAL CANDIDIASIS 31 0.0343
15 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1514 0.0324
16 PRODUCT CONFUSION 24 0.0302
17 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1360 0.0260
18 DEVICE MISUSE 34 0.0257
19 TOTAL LUNG CAPACITY DECREASED 40 0.0250
20 INCREASED UPPER AIRWAY SECRETION 123 0.0239
21 CANDIDA INFECTION 402 0.0238
22 INABILITY TO AFFORD MEDICATION 229 0.0230
23 SPUTUM INCREASED 49 0.0226
24 PRODUCT LABEL CONFUSION 132 0.0226
25 DYSPHONIA 1284 0.0219
26 VOCAL CORD DISORDER 43 0.0218
27 CATARACT OPERATION 120 0.0202
28 CANCER SURGERY 19 0.0198
29 ASTHMA 2220 0.0196
30 PRODUCT QUALITY ISSUE 2667 0.0196
31 LOWER RESPIRATORY TRACT CONGESTION 33 0.0194
32 REHABILITATION THERAPY 75 0.0193
33 WHEEZING 1144 0.0193
34 PHARYNGEAL DISORDER 55 0.0191
35 EXPIRED PRODUCT ADMINISTERED 621 0.0187
36 EMERGENCY CARE 56 0.0185
37 BRONCHITIS CHRONIC 45 0.0184
38 BRONCHIAL HYPERREACTIVITY 22 0.0183
39 OSTEOSCLEROSIS 28 0.0178
40 EMPHYSEMA 179 0.0177
41 CARDIOVERSION 24 0.0172
42 UNDERDOSE 1248 0.0171
43 ORAL CANDIDIASIS 223 0.0169
44 CHRONIC RESPIRATORY FAILURE 20 0.0166
45 ORAL FUNGAL INFECTION 45 0.0164
46 INCREASED BRONCHIAL SECRETION 41 0.0160
47 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 17 0.0160
48 DRUG ADMINISTRATION ERROR 469 0.0153
49 APHONIA 211 0.0151
50 DRUG DISPENSING ERROR 229 0.0150
51 MECHANICAL VENTILATION 28 0.0147
52 NEPHROGENIC ANAEMIA 68 0.0147
53 HYPERPARATHYROIDISM SECONDARY 36 0.0144
54 MULTIPLE ALLERGIES 111 0.0141
55 BRONCHIAL SECRETION RETENTION 18 0.0141
56 NOCTURNAL DYSPNOEA 18 0.0141
57 CHOKING SENSATION 77 0.0139
58 WRONG PATIENT RECEIVED MEDICATION 38 0.0139
59 TONGUE COATED 24 0.0139
60 BRONCHIAL DISORDER 21 0.0135
61 INTENSIVE CARE 19 0.0134
62 LUNG INFECTION 207 0.0133
63 DEVICE MECHANICAL ISSUE 177 0.0129
64 SMALL CELL LUNG CANCER 19 0.0126
65 PULMONARY FUNCTION TEST DECREASED 55 0.0126
66 EXPOSED BONE IN JAW 27 0.0124
67 CONJUNCTIVITIS ALLERGIC 18 0.0121
68 TONGUE DISCOLOURATION 53 0.0121
69 DRUG DOSE OMISSION 1998 0.0121
70 HAEMORRHAGIC ANAEMIA 53 0.0120
71 PRODUCT PACKAGING CONFUSION 29 0.0119
72 PULMONARY CONGESTION 156 0.0118
73 SECRETION DISCHARGE 146 0.0116
74 PULMONARY FUNCTION TEST ABNORMAL 18 0.0115
75 HERNIA REPAIR 30 0.0115
76 BRONCHITIS 845 0.0114
77 BRAIN OPERATION 26 0.0114
78 APPARENT DEATH 41 0.0114
79 LOBAR PNEUMONIA 21 0.0113
80 DYSPNOEA 6415 0.0113
81 SINUS OPERATION 27 0.0113
82 PRODUCTIVE COUGH 539 0.0113
83 RESPIRATORY TRACT CONGESTION 176 0.0111
84 ORAL MUCOSAL ERUPTION 17 0.0111
85 INTENTIONAL DEVICE MISUSE 48 0.0109
86 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 67 0.0108
87 CARDIAC OPERATION 93 0.0108
88 RESPIRATION ABNORMAL 74 0.0107
89 UPPER RESPIRATORY TRACT CONGESTION 31 0.0107
90 ENDOTRACHEAL INTUBATION 30 0.0107
91 PULMONARY MASS 158 0.0106
92 OESOPHAGEAL CANDIDIASIS 42 0.0105
93 RADIOTHERAPY 20 0.0104
94 ESSENTIAL HYPERTENSION 19 0.0104
95 SPUTUM DISCOLOURED 98 0.0103
96 INTERCEPTED MEDICATION ERROR 47 0.0101
97 STENT PLACEMENT 81 0.0100
98 PULMONARY PAIN 29 0.0099
99 PRODUCT DOSE OMISSION 648 0.0099
100 PHARYNGEAL ERYTHEMA 21 0.0099
101 ACUTE SINUSITIS 17 0.0098
102 RESPIRATORY SYMPTOM 28 0.0098
103 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 87 0.0098
104 DRY THROAT 100 0.0098
105 SPONDYLOLISTHESIS 17 0.0098
106 INTRAMEDULLARY ROD INSERTION 20 0.0098
107 ROTATOR CUFF REPAIR 17 0.0097
108 KYPHOSIS 17 0.0096
109 THROAT IRRITATION 430 0.0096
110 EXTRA DOSE ADMINISTERED 387 0.0095
111 UPPER-AIRWAY COUGH SYNDROME 77 0.0093
112 SUFFOCATION FEELING 23 0.0093
113 CARDIAC PACEMAKER INSERTION 55 0.0092
114 COUGH 2582 0.0092
115 RHINITIS ALLERGIC 40 0.0090
116 OBSTRUCTIVE AIRWAYS DISORDER 99 0.0089
117 OXYGEN SATURATION ABNORMAL 25 0.0088
118 MACULAR DEGENERATION 105 0.0088
119 DYSPNOEA EXERTIONAL 331 0.0088
120 REBOUND ACID HYPERSECRETION 26 0.0086
121 INCORRECT DOSAGE ADMINISTERED 42 0.0086
122 BREATH SOUNDS ABNORMAL 42 0.0085
123 LUNG DISORDER 414 0.0084
124 PRODUCT DOSE OMISSION ISSUE 2458 0.0084
125 VASCULAR GRAFT 24 0.0083
126 DEVICE DELIVERY SYSTEM ISSUE 228 0.0083
127 ATELECTASIS 79 0.0082
128 BRONCHIECTASIS 55 0.0082
129 CHOKING 156 0.0080
130 PRODUCT DISPENSING ERROR 174 0.0080
131 LIMB OPERATION 38 0.0079
132 GALLBLADDER OPERATION 32 0.0079
133 CORONARY ARTERIAL STENT INSERTION 40 0.0079
134 HIATUS HERNIA 102 0.0079
135 CHEST DISCOMFORT 806 0.0079
136 ATYPICAL PNEUMONIA 23 0.0077
137 INTERVERTEBRAL DISC DEGENERATION 71 0.0077
138 PRESCRIBED UNDERDOSE 153 0.0077
139 LUMBAR SPINAL STENOSIS 22 0.0075
140 PRODUCT CLEANING INADEQUATE 20 0.0075
141 HYPOPNOEA 26 0.0075
142 CANDIDIASIS 30 0.0075
143 PAINFUL RESPIRATION 18 0.0075
144 LIP PAIN 21 0.0073
145 INTENTIONAL PRODUCT MISUSE 640 0.0073
146 NECK SURGERY 17 0.0073
147 LUNG NEOPLASM MALIGNANT 300 0.0073
148 MEDICATION ERROR 403 0.0072
149 ORAL DISORDER 53 0.0072
150 SPINAL COLUMN STENOSIS 34 0.0072
151 SPINAL OSTEOARTHRITIS 63 0.0072
152 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 17 0.0072
153 ACCIDENTAL UNDERDOSE 103 0.0071
154 CORONARY ARTERY BYPASS 41 0.0071
155 RALES 41 0.0071
156 HIP SURGERY 38 0.0070
157 AORTIC ARTERIOSCLEROSIS 18 0.0070
158 GLAUCOMA 134 0.0070
159 SLEEP APNOEA SYNDROME 131 0.0069
160 SEASONAL ALLERGY 96 0.0068
161 PNEUMONIA 2186 0.0067
162 LOCAL SWELLING 117 0.0067
163 CHRONIC SINUSITIS 25 0.0067
164 OROPHARYNGEAL DISCOMFORT 60 0.0066
165 EYE OPERATION 30 0.0065
166 DENTAL CARIES 72 0.0065
167 PRODUCT TASTE ABNORMAL 88 0.0065
168 GLOSSITIS 23 0.0065
169 DEVICE ISSUE 580 0.0065
170 SCOLIOSIS 40 0.0065
171 ORAL DISCOMFORT 89 0.0064
172 BONE LESION 23 0.0064
173 DEVICE USE ISSUE 111 0.0063
174 MYCOBACTERIUM AVIUM COMPLEX INFECTION 17 0.0063
175 CATHETERISATION CARDIAC 28 0.0063
176 SHOULDER ARTHROPLASTY 17 0.0063
177 PNEUMOTHORAX 100 0.0063
178 THROMBOPHLEBITIS SUPERFICIAL 19 0.0063
179 OROPHARYNGEAL PAIN 574 0.0062
180 TONGUE DISCOMFORT 26 0.0061
181 CHOLECYSTITIS CHRONIC 41 0.0061
182 SINUS CONGESTION 82 0.0061
183 EXPIRED DEVICE USED 20 0.0060
184 OSTEOPENIA 91 0.0060
185 HYPERCAPNIA 18 0.0060
186 BRONCHOSPASM 85 0.0060
187 TONGUE DISORDER 43 0.0059
188 END STAGE RENAL DISEASE 108 0.0059
189 LARGE INTESTINE POLYP 41 0.0059
190 SINUS HEADACHE 35 0.0059
191 ORAL INFECTION 23 0.0059
192 ILL-DEFINED DISORDER 356 0.0059
193 OXYGEN SATURATION DECREASED 329 0.0058
194 SPINAL OPERATION 72 0.0058
195 RIB FRACTURE 120 0.0058
196 APHAGIA 28 0.0058
197 CHOLECYSTECTOMY 66 0.0058
198 FOREIGN BODY 23 0.0057
199 PRESCRIBED OVERDOSE 111 0.0057
200 DIVERTICULUM INTESTINAL 25 0.0057
201 SENSATION OF FOREIGN BODY 48 0.0057
202 NASAL POLYPS 28 0.0057
203 PROSTATOMEGALY 22 0.0056
204 LOOSE TOOTH 18 0.0056
205 PANIC REACTION 40 0.0055
206 DIVERTICULUM 39 0.0055
207 HIP ARTHROPLASTY 84 0.0055
208 THROAT CANCER 23 0.0054
209 DRUG PRESCRIBING ERROR 104 0.0054
210 PLEURISY 32 0.0054
211 HAEMOPTYSIS 150 0.0054
212 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 382 0.0054
213 UPPER RESPIRATORY TRACT INFECTION 247 0.0053
214 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 29 0.0053
215 TONGUE ULCERATION 18 0.0053
216 ORAL PAIN 119 0.0053
217 INTENTIONAL PRODUCT USE ISSUE 464 0.0053
218 CHEMOTHERAPY 20 0.0053
219 EXOSTOSIS 48 0.0053
220 CATARACT 313 0.0053
221 RESPIRATORY TRACT INFECTION 136 0.0052
222 TREATMENT NONCOMPLIANCE 285 0.0052
223 KNEE OPERATION 51 0.0052
224 GLOSSODYNIA 116 0.0052
225 OSTEOPOROSIS 213 0.0052
226 SPINAL FUSION SURGERY 21 0.0052
227 RESPIRATORY DISORDER 154 0.0051
228 SHOULDER OPERATION 22 0.0051
229 ACUTE RESPIRATORY FAILURE 99 0.0051
230 ROTATOR CUFF SYNDROME 66 0.0051
231 HOSPICE CARE 50 0.0051
232 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 17 0.0050
233 LOW TURNOVER OSTEOPATHY 20 0.0050
234 ARTERIOSCLEROSIS CORONARY ARTERY 33 0.0050
235 INTRACRANIAL ANEURYSM 20 0.0050
236 SINUS DISORDER 98 0.0049
237 NASAL CONGESTION 290 0.0049
238 LACERATION 46 0.0049
239 SPINAL FRACTURE 98 0.0049
240 FEELING JITTERY 93 0.0049
241 LOWER GASTROINTESTINAL HAEMORRHAGE 36 0.0049
242 AORTIC ANEURYSM 37 0.0049
243 COMPRESSION FRACTURE 26 0.0048
244 MEDICATION RESIDUE PRESENT 23 0.0048
245 BONE DISORDER 87 0.0048
246 SNEEZING 107 0.0048
247 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 81 0.0048
248 LUNG INFILTRATION 42 0.0048
249 LIGAMENT SPRAIN 47 0.0047
250 ASPIRATION 52 0.0047
251 UPPER LIMB FRACTURE 94 0.0047
252 INCORRECT PRODUCT STORAGE 62 0.0047
253 SPINAL COMPRESSION FRACTURE 39 0.0047
254 MENISCUS INJURY 29 0.0047
255 ANKLE FRACTURE 73 0.0047
256 CYSTIC FIBROSIS 26 0.0047
257 HIP FRACTURE 151 0.0047
258 CHRONIC KIDNEY DISEASE 355 0.0047
259 TRICUSPID VALVE INCOMPETENCE 37 0.0047
260 EXPIRED DRUG ADMINISTERED 23 0.0046
261 JOINT INJURY 99 0.0046
262 RHINORRHOEA 298 0.0046
263 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 154 0.0046
264 DISABILITY 90 0.0045
265 FOOT FRACTURE 86 0.0045
266 RENAL CYST 36 0.0045
267 PATHOLOGICAL FRACTURE 23 0.0045
268 MUSCULOSKELETAL CHEST PAIN 69 0.0045
269 TOOTH FRACTURE 49 0.0044
270 CARDIAC FAILURE CONGESTIVE 357 0.0044
271 OESOPHAGEAL DISORDER 17 0.0044
272 BACK INJURY 48 0.0044
273 FOOD ALLERGY 34 0.0044
274 WALKING AID USER 29 0.0044
275 CHAPPED LIPS 19 0.0044
276 NONSPECIFIC REACTION 24 0.0044
277 PELVIC FRACTURE 34 0.0044
278 RETCHING 93 0.0044
279 NASOPHARYNGITIS 801 0.0043
280 WRIST FRACTURE 52 0.0043
281 OESOPHAGEAL PAIN 17 0.0043
282 NEPHROPATHY 40 0.0043
283 SURGERY 251 0.0043
284 PRODUCT SUBSTITUTION ISSUE 246 0.0043
285 CHEILITIS 23 0.0042
286 ARTERIOSCLEROSIS 40 0.0042
287 DECREASED INTEREST 25 0.0042
288 KNEE ARTHROPLASTY 89 0.0042
289 BODY HEIGHT DECREASED 45 0.0042
290 HYPOXIA 148 0.0042
291 SINUSITIS 430 0.0042
292 SKIN ATROPHY 24 0.0042
293 GOITRE 17 0.0041
294 CARDIOMEGALY 51 0.0041
295 DRUG EFFECT DECREASED 223 0.0041
296 GINGIVAL SWELLING 18 0.0041
297 LIGAMENT RUPTURE 18 0.0041
298 GASTROOESOPHAGEAL REFLUX DISEASE 325 0.0040
299 GALLBLADDER DISORDER 72 0.0040
300 ANEURYSM 20 0.0040
301 PULMONARY FIBROSIS 77 0.0040
302 OSTEOARTHRITIS 170 0.0040
303 EXERCISE TOLERANCE DECREASED 23 0.0040
304 DEVICE DEFECTIVE 69 0.0040
305 PURULENT DISCHARGE 17 0.0040
306 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 806 0.0040
307 HOSPITALISATION 609 0.0040
308 ARTERIAL OCCLUSIVE DISEASE 31 0.0039
309 DEVICE MALFUNCTION 277 0.0039
310 HEART RATE INCREASED 389 0.0039
311 NERVOUSNESS 204 0.0039
312 IMPAIRED QUALITY OF LIFE 56 0.0039
313 GINGIVITIS 21 0.0039
314 PERIPHERAL VASCULAR DISORDER 20 0.0039
315 THROAT TIGHTNESS 105 0.0039
316 PRODUCT USE ISSUE 728 0.0039
317 INFLUENZA 429 0.0038
318 RESPIRATORY DISTRESS 106 0.0038
319 EOSINOPHIL COUNT INCREASED 32 0.0038
320 FOOT OPERATION 19 0.0038
321 NASAL DRYNESS 24 0.0038
322 DEVICE FAILURE 58 0.0038
323 BRAIN NEOPLASM MALIGNANT 17 0.0038
324 INFUSION SITE ERYTHEMA 32 0.0038
325 HYPERVENTILATION 22 0.0038
326 VITAMIN D DEFICIENCY 37 0.0038
327 SARCOIDOSIS 18 0.0038
328 VIRAL UPPER RESPIRATORY TRACT INFECTION 18 0.0038
329 NASAL DISCOMFORT 30 0.0038
330 JOINT DISLOCATION 40 0.0038
331 PULMONARY THROMBOSIS 41 0.0038
332 CONCUSSION 29 0.0037
333 DRUG INEFFECTIVE 4924 0.0037
334 LEFT VENTRICULAR DYSFUNCTION 25 0.0037
335 RHINITIS 30 0.0037
336 GLUCOSE TOLERANCE IMPAIRED 22 0.0037
337 DRY MOUTH 301 0.0037
338 STRESS FRACTURE 20 0.0037
339 PHARYNGEAL OEDEMA 57 0.0037
340 FULL BLOOD COUNT ABNORMAL 39 0.0037
341 INCORRECT ROUTE OF DRUG ADMINISTRATION 131 0.0037
342 EAR PAIN 71 0.0036
343 PERFORMANCE STATUS DECREASED 17 0.0036
344 MALAISE 1593 0.0036
345 CHEST PAIN 671 0.0036
346 ROAD TRAFFIC ACCIDENT 151 0.0036
347 BLOOD MAGNESIUM DECREASED 31 0.0036
348 ACTIVITIES OF DAILY LIVING IMPAIRED 71 0.0036
349 BACK DISORDER 58 0.0036
350 CARDIAC FLUTTER 23 0.0036
351 ULCER HAEMORRHAGE 24 0.0035
352 BURSITIS 43 0.0035
353 TOOTH ABSCESS 36 0.0035
354 PRODUCT DELIVERY MECHANISM ISSUE 19 0.0035
355 HYPERLIPIDAEMIA 42 0.0035
356 RENAL FAILURE CHRONIC 27 0.0035
357 CARDIAC VALVE DISEASE 20 0.0035
358 PSEUDOMONAS INFECTION 30 0.0035
359 DYSGRAPHIA 23 0.0035
360 PNEUMONIA BACTERIAL 32 0.0035
361 ARTHRITIS 274 0.0035
362 INCREASED TENDENCY TO BRUISE 32 0.0035
363 INTERVERTEBRAL DISC PROTRUSION 76 0.0035
364 THERAPEUTIC RESPONSE CHANGED 22 0.0035
365 HYPERKERATOSIS 19 0.0034
366 PULMONARY HYPERTENSION 71 0.0034
367 HAND FRACTURE 24 0.0034
368 TOOTH EXTRACTION 42 0.0034
369 OVERDOSE 728 0.0034
370 COLECTOMY 19 0.0034
371 COAGULOPATHY 56 0.0034
372 NERVE COMPRESSION 31 0.0034
373 IRON DEFICIENCY ANAEMIA 31 0.0034
374 TRANSFUSION 35 0.0033
375 PRODUCT RESIDUE PRESENT 18 0.0033
376 HEARING IMPAIRED 20 0.0033
377 PANIC ATTACK 121 0.0033
378 HEART RATE IRREGULAR 75 0.0033
379 POOR QUALITY SLEEP 71 0.0033
380 COLON CANCER 49 0.0033
381 ATRIAL FIBRILLATION 320 0.0033
382 POST-TRAUMATIC STRESS DISORDER 22 0.0033
383 EYE INFECTION 37 0.0033
384 LIMB INJURY 88 0.0032
385 MUSCLE STRAIN 28 0.0032
386 HYSTERECTOMY 28 0.0032
387 RESPIRATORY FAILURE 235 0.0032
388 FIBROMYALGIA 78 0.0032
389 SWOLLEN TONGUE 100 0.0032
390 STAPHYLOCOCCAL INFECTION 105 0.0032
391 IMPAIRED WORK ABILITY 68 0.0032
392 INFUSION SITE SWELLING 20 0.0032
393 CORONAVIRUS INFECTION 21 0.0032
394 OVERWEIGHT 17 0.0032
395 TENDON RUPTURE 39 0.0032
396 NERVE INJURY 35 0.0031
397 PHARYNGITIS 39 0.0031
398 GINGIVAL PAIN 25 0.0031
399 TERMINAL STATE 21 0.0031
400 MOUTH HAEMORRHAGE 23 0.0031
401 ATRIAL FLUTTER 25 0.0031
402 BLOOD POTASSIUM DECREASED 94 0.0031
403 LOWER LIMB FRACTURE 60 0.0031
404 CARDIAC MURMUR 27 0.0031
405 EAR DISCOMFORT 32 0.0031
406 ATRIOVENTRICULAR BLOCK 24 0.0031
407 STOMATITIS 188 0.0031
408 ACCIDENT 37 0.0031
409 TOOTHACHE 56 0.0031
410 ABNORMAL LOSS OF WEIGHT 21 0.0031
411 EYE DISCHARGE 32 0.0031
412 GOUT 55 0.0031
413 INTENTIONAL DRUG MISUSE 64 0.0031
414 DECREASED ACTIVITY 33 0.0031
415 SPEECH DISORDER 160 0.0031
416 THYROID DISORDER 47 0.0030
417 HEART RATE ABNORMAL 17 0.0030
418 BRAIN NEOPLASM 28 0.0030
419 DIABETES MELLITUS 230 0.0030
420 LACRIMATION INCREASED 91 0.0030
421 RIGHT VENTRICULAR FAILURE 21 0.0030
422 VIRAL INFECTION 99 0.0030
423 HEAD INJURY 94 0.0030
424 THERMAL BURN 21 0.0030
425 INJURY 208 0.0030
426 PHARYNGITIS STREPTOCOCCAL 32 0.0030
427 MIDDLE INSOMNIA 55 0.0029
428 FALL 980 0.0029
429 EAR INFECTION 78 0.0029
430 OSTEOMYELITIS 53 0.0029
431 VITAMIN D DECREASED 25 0.0029
432 HYPERCHOLESTEROLAEMIA 28 0.0029
433 DEFORMITY 27 0.0029
434 ADRENAL INSUFFICIENCY 35 0.0029
435 CARPAL TUNNEL SYNDROME 40 0.0029
436 DYSGEUSIA 212 0.0029
437 BIPOLAR DISORDER 31 0.0028
438 DIVERTICULITIS 79 0.0028
439 ODYNOPHAGIA 17 0.0028
440 THERAPY CHANGE 28 0.0028
441 PARAESTHESIA ORAL 41 0.0028
442 INTENTIONAL DOSE OMISSION 81 0.0028
443 SYMPTOM RECURRENCE 17 0.0028
444 TOOTH DISORDER 63 0.0028
445 NEOPLASM MALIGNANT 189 0.0028
446 DEEP VEIN THROMBOSIS 184 0.0028
447 INITIAL INSOMNIA 29 0.0028
448 FOREIGN BODY SENSATION IN EYES 18 0.0028
449 AGEUSIA 70 0.0028
450 VISUAL ACUITY REDUCED 93 0.0028
451 LOWER RESPIRATORY TRACT INFECTION 127 0.0028
452 PAIN IN JAW 79 0.0028
453 TRANSIENT ISCHAEMIC ATTACK 94 0.0028
454 DRUG EFFECT INCOMPLETE 101 0.0028
455 TREMOR 458 0.0028
456 RESTLESS LEGS SYNDROME 50 0.0027
457 LYMPHOEDEMA 19 0.0027
458 CARDIAC DISORDER 257 0.0027
459 CORONARY ARTERY DISEASE 83 0.0027
460 PALPITATIONS 321 0.0027
461 MITRAL VALVE INCOMPETENCE 31 0.0027
462 THERAPEUTIC RESPONSE DECREASED 166 0.0027
463 PRODUCT STORAGE ERROR 239 0.0027
464 RENAL INJURY 81 0.0027
465 BLOOD CHOLESTEROL INCREASED 127 0.0027
466 THERAPEUTIC RESPONSE UNEXPECTED 122 0.0027
467 ARTHROPOD BITE 20 0.0027
468 SCIATICA 43 0.0027
469 ANOSMIA 39 0.0027
470 PULMONARY HAEMORRHAGE 21 0.0027
471 DEMENTIA 75 0.0027
472 PULMONARY EMBOLISM 255 0.0027
473 BREAST MASS 18 0.0027
474 OSTEONECROSIS OF JAW 66 0.0027
475 CELLULITIS 134 0.0027
476 IMMUNE SYSTEM DISORDER 35 0.0027
477 HYPOAESTHESIA ORAL 40 0.0027
478 DECREASED IMMUNE RESPONSIVENESS 26 0.0026
479 EYE DISORDER 87 0.0026
480 RENAL FAILURE 351 0.0026
481 HERNIA 51 0.0026
482 VISUAL FIELD DEFECT 19 0.0026
483 ANHEDONIA 69 0.0026
484 BLOOD DISORDER 21 0.0026
485 BLOOD SODIUM DECREASED 49 0.0026
486 TENDONITIS 40 0.0026
487 HYPERTENSION 547 0.0026
488 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 124 0.0026
489 MYOCARDIAL INFARCTION 450 0.0026
490 CYST 32 0.0026
491 FACIAL PAIN 23 0.0026
492 CLOSTRIDIUM DIFFICILE INFECTION 56 0.0026
493 APPETITE DISORDER 17 0.0026
494 ADVERSE REACTION 34 0.0026
495 OESOPHAGITIS 28 0.0026
496 CHOLELITHIASIS 84 0.0026
497 MULTIPLE FRACTURES 42 0.0026
498 CORONARY ARTERY OCCLUSION 35 0.0025
499 BLOOD IRON DECREASED 30 0.0025
500 HERPES ZOSTER 145 0.0025
501 PAROSMIA 19 0.0025
502 FLUID RETENTION 128 0.0025
503 BLOOD PRESSURE ABNORMAL 50 0.0025
504 SCAR 43 0.0025
505 ABASIA 62 0.0025
506 AMNESIA 163 0.0025
507 EPISTAXIS 187 0.0025
508 PLEURAL EFFUSION 152 0.0025
509 GASTROENTERITIS VIRAL 45 0.0025
510 FEAR 67 0.0025
511 ACCIDENTAL OVERDOSE 91 0.0025
512 ECCHYMOSIS 17 0.0025
513 BLINDNESS 101 0.0025
514 PERICARDIAL EFFUSION 57 0.0025
515 THROMBOSIS 198 0.0025
516 PHARYNGEAL SWELLING 24 0.0025
517 CYSTITIS 78 0.0024
518 LEUKAEMIA 23 0.0024
519 METASTASES TO BONE 40 0.0024
520 NEOPLASM 28 0.0024
521 DYSPHAGIA 231 0.0024
522 NECK PAIN 136 0.0024
523 TOOTH INFECTION 32 0.0024
524 ELECTROCARDIOGRAM ABNORMAL 19 0.0024
525 HEPATIC STEATOSIS 45 0.0024
526 MUSCLE SPASMS 443 0.0024
527 MALNUTRITION 27 0.0024
528 INFUSION SITE PAIN 31 0.0024
529 CONTUSION 231 0.0024
530 TENDERNESS 25 0.0024
531 PRODUCT USE IN UNAPPROVED INDICATION 593 0.0024
532 GROIN PAIN 21 0.0024
533 NODULE 31 0.0024
534 FUNGAL INFECTION 79 0.0024
535 INCORRECT DOSE ADMINISTERED BY DEVICE 62 0.0024
536 INCONTINENCE 25 0.0024
537 DYSURIA 87 0.0024
538 BACTERIAL INFECTION 44 0.0024
539 APHASIA 71 0.0023
540 COELIAC DISEASE 23 0.0023
541 ADVERSE EVENT 215 0.0023
542 MUSCULOSKELETAL DISCOMFORT 40 0.0023
543 OBESITY 37 0.0023
544 LEUKOCYTOSIS 42 0.0023
545 BACK PAIN 539 0.0023
546 LIP DRY 21 0.0023
547 VISION BLURRED 317 0.0023
548 HAEMORRHOIDS 45 0.0023
549 RESPIRATORY SYNCYTIAL VIRUS INFECTION 20 0.0023
550 ANXIETY 653 0.0023
551 EYE PAIN 129 0.0023
552 PRODUCT USE COMPLAINT 36 0.0023
553 SECOND PRIMARY MALIGNANCY 19 0.0023
554 IMMUNODEFICIENCY 34 0.0023
555 GASTRITIS 60 0.0023
556 TOOTH LOSS 47 0.0023
557 CEREBROVASCULAR ACCIDENT 384 0.0023
558 WOUND 63 0.0023
559 EYE HAEMORRHAGE 30 0.0022
560 SWELLING FACE 146 0.0022
561 MOUTH ULCERATION 47 0.0022
562 GASTROINTESTINAL HAEMORRHAGE 186 0.0022
563 PRODUCT PRESCRIBING ERROR 53 0.0022
564 NOCTURIA 27 0.0022
565 BONE PAIN 130 0.0022
566 DEAFNESS 58 0.0022
567 DECUBITUS ULCER 18 0.0022
568 IMPAIRED GASTRIC EMPTYING 30 0.0022
569 INCORRECT DOSE ADMINISTERED 502 0.0022
570 TYPE 2 DIABETES MELLITUS 74 0.0022
571 PRODUCT AVAILABILITY ISSUE 50 0.0022
572 FEMUR FRACTURE 68 0.0022
573 SUPRAVENTRICULAR TACHYCARDIA 21 0.0022
574 INTERNAL HAEMORRHAGE 25 0.0022
575 CONDITION AGGRAVATED 665 0.0022
576 GASTRIC DISORDER 75 0.0022
577 FEELING ABNORMAL 523 0.0022
578 CHOLECYSTITIS 26 0.0022
579 THERAPY CESSATION 112 0.0022
580 BLOOD COUNT ABNORMAL 33 0.0022
581 EYE PRURITUS 73 0.0022
582 PNEUMONITIS 59 0.0022
583 BLOOD CALCIUM INCREASED 19 0.0022
584 MENTAL STATUS CHANGES 60 0.0022
585 HYPERSENSITIVITY 399 0.0021
586 PULMONARY OEDEMA 95 0.0021
587 WRONG TECHNIQUE IN DRUG USAGE PROCESS 77 0.0021
588 MUSCULOSKELETAL PAIN 111 0.0021
589 BLADDER DISORDER 21 0.0021
590 HYPOACUSIS 91 0.0021
591 SPINAL DISORDER 20 0.0021
592 PRODUCT PACKAGING ISSUE 20 0.0021
593 SCAB 24 0.0021
594 WOUND INFECTION 23 0.0021
595 RENAL FAILURE ACUTE 89 0.0021
596 BALANCE DISORDER 181 0.0021
597 INSURANCE ISSUE 32 0.0021
598 POST PROCEDURAL INFECTION 17 0.0021
599 LYMPHADENOPATHY 74 0.0021
600 ARTHROPATHY 116 0.0021
601 TUBULOINTERSTITIAL NEPHRITIS 39 0.0021
602 DIPLOPIA 54 0.0021
603 FOOT DEFORMITY 23 0.0021
604 LIP SWELLING 69 0.0021
605 MEMORY IMPAIRMENT 284 0.0021
606 VISUAL IMPAIRMENT 256 0.0021
607 MENTAL IMPAIRMENT 50 0.0021
608 INSOMNIA 545 0.0020
609 ECONOMIC PROBLEM 31 0.0020
610 DIALYSIS 29 0.0020
611 COLD SWEAT 36 0.0020
612 PNEUMONIA ASPIRATION 51 0.0020
613 HYPOTHYROIDISM 65 0.0020
614 INTRAOCULAR PRESSURE INCREASED 26 0.0020
615 RESPIRATORY RATE INCREASED 18 0.0020
616 DRY EYE 101 0.0020
617 SKIN LACERATION 22 0.0020
618 DIZZINESS 1005 0.0020
619 GAIT DISTURBANCE 385 0.0020
620 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 143 0.0020
621 BRAIN INJURY 20 0.0020
622 ASTHENIA 748 0.0020
623 BLOOD PRESSURE INCREASED 304 0.0020
624 BLINDNESS UNILATERAL 28 0.0020
625 IMPAIRED HEALING 65 0.0020
626 ADVERSE DRUG REACTION 177 0.0020
627 URINARY TRACT INFECTION 336 0.0020
628 SLEEP DISORDER 139 0.0020
629 SARS-COV-2 TEST POSITIVE 26 0.0020
630 EYE SWELLING 73 0.0020
631 DYSPEPSIA 193 0.0020
632 OEDEMA PERIPHERAL 238 0.0020
633 ULCER 31 0.0019
634 LOCALISED INFECTION 47 0.0019
635 PRURITUS GENERALISED 42 0.0019
636 KIDNEY INFECTION 38 0.0019
637 VITREOUS FLOATERS 19 0.0019
638 MASS 27 0.0019
639 RED BLOOD CELL COUNT DECREASED 55 0.0019
640 RESPIRATORY ARREST 53 0.0019
641 FLANK PAIN 18 0.0019
642 PRODUCT ODOUR ABNORMAL 20 0.0019
643 INFECTION 276 0.0019
644 SINUS TACHYCARDIA 27 0.0019
645 SKIN ULCER 49 0.0019
646 HAEMATOMA 49 0.0019
647 URINARY INCONTINENCE 56 0.0019
648 CLOSTRIDIUM DIFFICILE COLITIS 20 0.0019
649 ANGINA PECTORIS 54 0.0019
650 INFLUENZA LIKE ILLNESS 155 0.0019
651 OCULAR DISCOMFORT 21 0.0019
652 HYPOAESTHESIA 279 0.0019
653 COVID-19 PNEUMONIA 22 0.0019
654 BASAL CELL CARCINOMA 29 0.0019
655 INTESTINAL OBSTRUCTION 70 0.0019
656 MUSCLE TIGHTNESS 30 0.0019
657 BLOOD TEST ABNORMAL 26 0.0018
658 RETINAL DETACHMENT 17 0.0018
659 NEUROPATHY PERIPHERAL 175 0.0018
660 OFF LABEL USE 1611 0.0018
661 HEPATOMEGALY 18 0.0018
662 GINGIVAL BLEEDING 25 0.0018
663 VENTRICULAR EXTRASYSTOLES 19 0.0018
664 URINARY RETENTION 61 0.0018
665 WEIGHT FLUCTUATION 19 0.0018
666 HAEMATOCRIT DECREASED 36 0.0018
667 MUSCLE ATROPHY 23 0.0018
668 ACUTE KIDNEY INJURY 277 0.0018
669 PSYCHOMOTOR HYPERACTIVITY 30 0.0018
670 DEHYDRATION 241 0.0018
671 OVARIAN CYST 18 0.0018
672 BONE LOSS 27 0.0018
673 MALIGNANT MELANOMA 24 0.0018
674 PRODUCT PRESCRIBING ISSUE 39 0.0018
675 SMALL INTESTINAL OBSTRUCTION 22 0.0018
676 FULL BLOOD COUNT DECREASED 36 0.0018
677 CYANOSIS 28 0.0018
678 HEADACHE 1112 0.0018
679 WHITE BLOOD CELL COUNT INCREASED 68 0.0018
680 PRESYNCOPE 43 0.0018
681 HAIR COLOUR CHANGES 22 0.0018
682 SLUGGISHNESS 18 0.0018
683 BODY TEMPERATURE INCREASED 36 0.0018
684 SWELLING 165 0.0018
685 IMPAIRED DRIVING ABILITY 20 0.0018
686 DERMATITIS CONTACT 20 0.0018
687 MICTURITION URGENCY 20 0.0017
688 RECTAL HAEMORRHAGE 75 0.0017
689 PAIN 1072 0.0017
690 TINNITUS 80 0.0017
691 RENAL TUBULAR NECROSIS 17 0.0017
692 DEPRESSION 394 0.0017
693 WEIGHT DECREASED 483 0.0017
694 DISCOMFORT 105 0.0017
695 HAIR TEXTURE ABNORMAL 23 0.0017
696 POST PROCEDURAL COMPLICATION 33 0.0017
697 QUALITY OF LIFE DECREASED 23 0.0017
698 GASTROENTERITIS 25 0.0017
699 HYPERSOMNIA 49 0.0017
700 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 308 0.0017
701 PAIN IN EXTREMITY 503 0.0017
702 MUSCULAR WEAKNESS 194 0.0017
703 SKIN INFECTION 19 0.0017
704 BLOOD URINE PRESENT 32 0.0017
705 VAGINAL DISCHARGE 17 0.0017
706 IRRITABLE BOWEL SYNDROME 36 0.0017
707 JOINT STIFFNESS 44 0.0017
708 FEEDING DISORDER 34 0.0017
709 MIGRAINE 160 0.0017
710 UPPER GASTROINTESTINAL HAEMORRHAGE 28 0.0017
711 OEDEMA 90 0.0017
712 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 91 0.0017
713 BURNING SENSATION 116 0.0017
714 FLUID OVERLOAD 24 0.0016
715 MADAROSIS 19 0.0016
716 ELECTROLYTE IMBALANCE 19 0.0016
717 LOSS OF CONSCIOUSNESS 209 0.0016
718 RASH GENERALISED 42 0.0016
719 BLISTER 91 0.0016
720 FEELING COLD 45 0.0016
721 INTERNATIONAL NORMALISED RATIO INCREASED 46 0.0016
722 RASH PRURITIC 87 0.0016
723 DEVICE BREAKAGE 65 0.0016
724 BLOOD CALCIUM DECREASED 18 0.0016
725 HEAD DISCOMFORT 28 0.0016
726 WEIGHT INCREASED 353 0.0016
727 URTICARIA 264 0.0016
728 ANAEMIA 299 0.0016
729 THIRST 28 0.0016
730 JOINT RANGE OF MOTION DECREASED 21 0.0016
731 NEURALGIA 38 0.0016
732 SEPSIS 174 0.0016
733 VERTIGO 95 0.0016
734 POLLAKIURIA 65 0.0016
735 ABNORMAL DREAMS 43 0.0016
736 ANAPHYLACTIC REACTION 86 0.0016
737 CARDIOMYOPATHY 23 0.0016
738 FATIGUE 1210 0.0016
739 CHILLS 181 0.0015
740 ARRHYTHMIA 73 0.0015
741 BLOOD POTASSIUM INCREASED 25 0.0015
742 MENTAL DISORDER 67 0.0015
743 GENERALISED OEDEMA 19 0.0015
744 ILLNESS 158 0.0015
745 COVID-19 269 0.0015
746 CONSTIPATION 334 0.0015
747 EYE IRRITATION 88 0.0015
748 INTENTIONAL OVERDOSE 98 0.0015
749 MOVEMENT DISORDER 49 0.0015
750 HYPOPHAGIA 39 0.0015
751 BEDRIDDEN 20 0.0015
752 FLATULENCE 86 0.0015
753 CARDIAC ARREST 125 0.0015
754 GENERAL PHYSICAL HEALTH DETERIORATION 175 0.0015
755 PERIPHERAL SWELLING 233 0.0015
756 HEART RATE DECREASED 53 0.0015
757 CONVULSION 86 0.0015
758 EATING DISORDER 32 0.0015
759 THINKING ABNORMAL 28 0.0015
760 JOINT SWELLING 181 0.0015
761 LETHARGY 86 0.0015
762 DEVICE RELATED INFECTION 23 0.0015
763 DEVICE OCCLUSION 21 0.0015
764 PHOTOPHOBIA 28 0.0015
765 PRODUCT DOSE OMISSION IN ERROR 42 0.0015
766 NEPHROLITHIASIS 68 0.0015
767 MYALGIA 252 0.0015
768 RENAL DISORDER 69 0.0015
769 HEMIPARESIS 25 0.0015
770 ABDOMINAL DISTENSION 154 0.0015
771 DYSSTASIA 43 0.0015
772 METASTASES TO LUNG 17 0.0015
773 MUSCULOSKELETAL DISORDER 28 0.0015
774 CONJUNCTIVITIS 27 0.0015
775 HAEMOGLOBIN DECREASED 149 0.0014
776 HOT FLUSH 109 0.0014
777 SKIN CANCER 31 0.0014
778 BREAST CANCER 134 0.0014
779 HEPATIC CIRRHOSIS 27 0.0014
780 PRODUCT ADMINISTRATION ERROR 29 0.0014
781 MOBILITY DECREASED 103 0.0014
782 PYREXIA 496 0.0014
783 SENSORY DISTURBANCE 23 0.0014
784 EXPOSURE VIA SKIN CONTACT 37 0.0014
785 SKIN LESION 39 0.0014
786 GASTRIC ULCER 27 0.0014
787 ARTHRALGIA 589 0.0014
788 EXPOSURE DURING PREGNANCY 88 0.0014
789 MOOD SWINGS 45 0.0014
790 HYPOKALAEMIA 65 0.0014
791 PARAESTHESIA 221 0.0014
792 BRAIN FOG 22 0.0014
793 FEELING HOT 86 0.0014
794 RASH ERYTHEMATOUS 67 0.0014
795 ABDOMINAL DISCOMFORT 235 0.0014
796 PANCREATITIS 74 0.0014
797 PARALYSIS 20 0.0014
798 CARDIAC FAILURE 112 0.0014
799 SKIN DISCOLOURATION 64 0.0014
800 ABDOMINAL PAIN UPPER 286 0.0014
801 DRUG INTOLERANCE 134 0.0014
802 BLOOD PRESSURE DECREASED 92 0.0014
803 TASTE DISORDER 28 0.0014
804 HAEMATURIA 47 0.0014
805 HYPOMAGNESAEMIA 19 0.0014
806 DECREASED APPETITE 316 0.0014
807 LIMB DISCOMFORT 42 0.0014
808 CRYING 49 0.0013
809 MUSCULOSKELETAL STIFFNESS 118 0.0013
810 ABDOMINAL PAIN LOWER 34 0.0013
811 RASH MACULAR 47 0.0013
812 THERAPEUTIC PRODUCT EFFECT DECREASED 60 0.0013
813 NIGHT SWEATS 43 0.0013
814 ORAL HERPES 26 0.0013
815 FRACTURE 25 0.0013
816 SYNCOPE 132 0.0013
817 UNRESPONSIVE TO STIMULI 34 0.0013
818 NAUSEA 1038 0.0013
819 PERIPHERAL COLDNESS 18 0.0013
820 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
821 METASTASES TO LIVER 23 0.0013
822 OCULAR HYPERAEMIA 62 0.0013
823 VOMITING 614 0.0013
824 NERVOUS SYSTEM DISORDER 40 0.0013
825 COMA 61 0.0013
826 DIARRHOEA 824 0.0013
827 EMOTIONAL DISORDER 39 0.0013
828 EMOTIONAL DISTRESS 153 0.0013
829 HYPERHIDROSIS 161 0.0012
830 BLOOD ALKALINE PHOSPHATASE INCREASED 31 0.0012
831 RASH 542 0.0012
832 ERUCTATION 24 0.0012
833 ABDOMINAL PAIN 288 0.0012
834 GAIT INABILITY 41 0.0012
835 LABORATORY TEST ABNORMAL 36 0.0012
836 INJECTION SITE BRUISING 97 0.0012
837 HYPOTENSION 243 0.0012
838 ECZEMA 63 0.0012
839 EOSINOPHILIA 21 0.0012
840 CHROMATURIA 27 0.0012
841 ABSCESS 19 0.0012
842 NIGHTMARE 41 0.0012
843 PRURITUS 453 0.0012
844 HAEMORRHAGE 123 0.0012
845 HYPERTHYROIDISM 17 0.0012
846 HYPOKINESIA 17 0.0012
847 FLUSHING 119 0.0012
848 LIVER FUNCTION TEST ABNORMAL 34 0.0012
849 LYMPHOMA 18 0.0012
850 CONFUSIONAL STATE 187 0.0012
851 RHEUMATOID ARTHRITIS 131 0.0012
852 SKIN HAEMORRHAGE 17 0.0011
853 DERMATITIS 24 0.0011
854 PANCREATIC CARCINOMA 33 0.0011
855 PALLOR 31 0.0011
856 MOOD ALTERED 31 0.0011
857 DISORIENTATION 45 0.0011
858 BLOOD TRIGLYCERIDES INCREASED 20 0.0011
859 DIABETES MELLITUS INADEQUATE CONTROL 20 0.0011
860 BLOOD PRESSURE FLUCTUATION 27 0.0011
861 INJECTION SITE WARMTH 23 0.0011
862 BLOOD CREATININE INCREASED 73 0.0011
863 CEREBRAL HAEMORRHAGE 40 0.0011
864 BONE DENSITY DECREASED 35 0.0011
865 DEATH 959 0.0011
866 HYPERKALAEMIA 39 0.0011
867 TACHYCARDIA 98 0.0011
868 AGITATION 81 0.0011
869 PARANOIA 19 0.0011
870 DERMATITIS ATOPIC 58 0.0011
871 HYPERGLYCAEMIA 40 0.0011
872 MANIA 18 0.0011
873 ORTHOSTATIC HYPOTENSION 19 0.0011
874 COLITIS 41 0.0011
875 ALOPECIA 212 0.0011
876 PLASMA CELL MYELOMA 42 0.0011
877 INJECTION SITE RASH 33 0.0011
878 DISTURBANCE IN ATTENTION 58 0.0011
879 UNEVALUABLE EVENT 81 0.0011
880 INCORRECT DRUG ADMINISTRATION DURATION 30 0.0011
881 INFLAMMATION 55 0.0011
882 DYSARTHRIA 40 0.0011
883 FAECES DISCOLOURED 23 0.0011
884 GASTROINTESTINAL DISORDER 95 0.0011
885 PELVIC PAIN 19 0.0010
886 INJECTION SITE PAIN 320 0.0010
887 SOMNOLENCE 210 0.0010
888 DEVICE DIFFICULT TO USE 69 0.0010
889 MUSCLE TWITCHING 24 0.0010
890 IRRITABILITY 62 0.0010
891 RASH PAPULAR 23 0.0010
892 HAEMATEMESIS 26 0.0010
893 SKIN FISSURES 20 0.0010
894 PANCREATITIS ACUTE 23 0.0010
895 BLOOD UREA INCREASED 17 0.0010
896 HAEMATOCHEZIA 56 0.0010
897 DRUG DOSE OMISSION BY DEVICE 79 0.0010
898 BLOOD GLUCOSE DECREASED 48 0.0010
899 PRODUCT PHYSICAL ISSUE 20 0.0010
900 SYSTEMIC LUPUS ERYTHEMATOSUS 35 0.0010
901 MULTIPLE SCLEROSIS 47 0.0010
902 ANGER 33 0.0010
903 SUICIDAL IDEATION 89 0.0010
904 THERAPY INTERRUPTED 69 0.0010
905 ERYTHEMA 198 0.0010
906 CARDIO-RESPIRATORY ARREST 40 0.0010
907 HYPOCALCAEMIA 18 0.0010
908 ACUTE MYOCARDIAL INFARCTION 28 0.0009
909 DEPRESSED MOOD 50 0.0009
910 OSTEONECROSIS 31 0.0009
911 INCREASED APPETITE 18 0.0009
912 ABNORMAL BEHAVIOUR 37 0.0009
913 LIVER DISORDER 41 0.0009
914 WHITE BLOOD CELL COUNT DECREASED 99 0.0009
915 SKIN EXFOLIATION 77 0.0009
916 DYSKINESIA 37 0.0009
917 HEPATIC ENZYME INCREASED 62 0.0009
918 CARDIOVASCULAR DISORDER 23 0.0009
919 SKIN DISORDER 30 0.0009
920 SEPTIC SHOCK 39 0.0009
921 ANAPHYLACTIC SHOCK 23 0.0009
922 DISEASE PROGRESSION 104 0.0009
923 BLOOD GLUCOSE INCREASED 165 0.0009
924 HYPONATRAEMIA 49 0.0009
925 INJECTION SITE PRURITUS 58 0.0009
926 MULTIPLE SCLEROSIS RELAPSE 59 0.0009
927 RENAL IMPAIRMENT 71 0.0008
928 INFUSION RELATED REACTION 56 0.0008
929 PROCEDURAL PAIN 23 0.0008
930 ASCITES 24 0.0008
931 INJECTION SITE URTICARIA 20 0.0008
932 COGNITIVE DISORDER 38 0.0008
933 INJECTION SITE MASS 30 0.0008
934 VAGINAL HAEMORRHAGE 35 0.0008
935 RESTLESSNESS 29 0.0008
936 INJECTION SITE ERYTHEMA 97 0.0008
937 TARDIVE DYSKINESIA 22 0.0008
938 PSORIASIS 100 0.0008
939 HEPATIC FAILURE 23 0.0008
940 CONTRAINDICATED PRODUCT ADMINISTERED 23 0.0008
941 INJECTION SITE SWELLING 57 0.0007
942 DRUG INTERACTION 118 0.0007
943 INTERSTITIAL LUNG DISEASE 36 0.0007
944 THROMBOCYTOPENIA 83 0.0007
945 INJECTION SITE HAEMORRHAGE 59 0.0007
946 ACCIDENTAL EXPOSURE TO PRODUCT 76 0.0007
947 DISEASE RECURRENCE 35 0.0007
948 PLATELET COUNT DECREASED 78 0.0007
949 HALLUCINATION 55 0.0007
950 PROSTATE CANCER 58 0.0007
951 ASPARTATE AMINOTRANSFERASE INCREASED 38 0.0007
952 PSORIATIC ARTHROPATHY 29 0.0007
953 THERAPY NON-RESPONDER 32 0.0007
954 MUCOSAL INFLAMMATION 18 0.0007
955 LEUKOPENIA 34 0.0007
956 GLYCOSYLATED HAEMOGLOBIN INCREASED 17 0.0007
957 SEIZURE 77 0.0007
958 COLITIS ULCERATIVE 29 0.0006
959 DEVICE LEAKAGE 28 0.0006
960 BLADDER CANCER 37 0.0006
961 AGGRESSION 31 0.0006
962 ALANINE AMINOTRANSFERASE INCREASED 38 0.0006
963 INJECTION SITE REACTION 42 0.0006
964 DRY SKIN 81 0.0006
965 OESOPHAGEAL CARCINOMA 17 0.0006
966 THERAPEUTIC RESPONSE SHORTENED 19 0.0006
967 TREATMENT FAILURE 47 0.0006
968 BRADYCARDIA 30 0.0006
969 HYPOGLYCAEMIA 27 0.0006
970 DELIRIUM 19 0.0005
971 NEUTROPENIA 72 0.0005
972 MALIGNANT NEOPLASM PROGRESSION 53 0.0005
973 WITHDRAWAL SYNDROME 21 0.0005
974 PANCYTOPENIA 27 0.0005
975 DEVICE DISLOCATION 21 0.0005
976 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
977 ANGIOEDEMA 21 0.0005
978 ELECTROCARDIOGRAM QT PROLONGED 17 0.0005
979 RENAL CANCER 21 0.0004
980 FEBRILE NEUTROPENIA 29 0.0004
981 RHABDOMYOLYSIS 18 0.0004
982 NO ADVERSE EVENT 77 0.0004
983 SKIN IRRITATION 19 0.0004
984 ACNE 29 0.0004
985 SUICIDE ATTEMPT 23 0.0004
986 DRUG WITHDRAWAL SYNDROME 31 0.0004
987 SKIN BURNING SENSATION 23 0.0003
988 MATERNAL EXPOSURE DURING PREGNANCY 20 0.0002
989 DRUG DEPENDENCE 31 0.0002
990 TOXICITY TO VARIOUS AGENTS 29 0.0002